Clarify a point for Multiepitope vaccine construction that
1) one should construct 3D structure of MEV with protein adjuvant sequence (A.A) or without it.
2)3D structure refinement, validation, solubility, docking MD simulation and plasmid construction: are these steps also require MEV with adjuvant a.a sequence or not?